MitrAssist

MitrAssist

Minimally invasive approach to Mitral heart value surgery.

HQ location
Misgav, Israel
Launch date
Employees
Enterprise value
$400—600m
Company register number
514263789
Recent deals
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor investor investor

€0.0

round
investor investor investor investor investor investor

€0.0

Valuation: €0.0

round
*

$100m

Series C
Total Funding000k
More about MitrAssist
Made with AI
Edit

MitrAssist is a medical device company specializing in minimally invasive treatments for Mitral Regurgitation (MR), a condition affecting the heart's mitral valve. The company targets patients who are unable to undergo risky open-heart surgery, providing a safer alternative with its innovative mitral valve implant. This implant works in harmony with the natural mitral valve, preserving its functionality and adapting to various anatomical shapes. MitrAssist operates in the healthcare market, specifically focusing on cardiology and medical devices. The business model revolves around the development, manufacturing, and distribution of its proprietary mitral valve implants to hospitals and healthcare providers. Revenue is generated through the sale of these implants and associated medical services. The company's solution is designed to be long-lasting, significantly reducing both the procedure and recovery times for patients, making it suitable for individuals of all ages.

Keywords: Mitral Regurgitation, minimally invasive, heart valve, cardiology, medical device, healthcare, patient safety, implant, recovery time, innovative treatment.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by MitrAssist

Edit